Docetaxel (docivyx), 1 mg
Products billed under this code include Docivyx.
Payment limit per 1 MG, by effective quarter, 1Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Docivyx.
Payment limit per 1 MG, by effective quarter, 1Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Docivyx | Avyxa Pharma, LLC | 83831-0101-02 | 20 | $923.86 |
| Docivyx | Avyxa Pharma, LLC | 83831-0102-08 | 80 | $3,695.44 |
| Docivyx | Avyxa Pharma, LLC | 83831-0103-16 | 160 | $7,390.88 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $46.193 | −$0.094 | 1 MG | Docetaxel (docivyx), 1 mg | v1, posted September 17, 2026 |
| 3Q26 | $46.287 | −$4.32 | 1 MG | Docetaxel (docivyx), 1 mg | v1, posted September 15, 2026 |
| 2Q26 | $50.607 | +$0.85 | 1 MG | Docetaxel (docivyx), 1 mg | v1, posted September 15, 2026 |
| 1Q26 | $49.757 | −$1.021 | 1 MG | Docetaxel (docivyx), 1 mg | v1, posted September 15, 2026 |
| 4Q25 | $50.778 | +$1.701 | 1 MG | Docetaxel (docivyx), 1 mg | v1, posted September 8, 2026 |
| 3Q25 | $49.077 | −$2.543 | 1 MG | Docetaxel (docivyx), 1 mg | v1, posted March 10, 2026 |
| 2Q25 | $51.62 | −$0.591 | 1 MG | Docetaxel (docivyx), 1 mg | v1, posted March 10, 2026 |
| 1Q25 | $52.211 | – | 1 MG | Docetaxel (docivyx), 1 mg | v1, posted December 19, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.